Cancers

Blood and bone marrow cancer

Mistry H, Nduka C, Connock M, et al Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. 2017

Mistry H, Nduka C, Connock M, et al Venetoclax for treating chronic lymphocytic leukaemia. A Single Technology Appraisal. 2017

Loveman E, Cooper K, Bryant J, Colquitt J, Frampton G, Clegg A. Dasatinib, high dose imatinib and nilotinib for the treatment of imatinib-resistant chronic myeloid leukaemia: a systematic review and economic evaluation. Health Technology Assessment. 2012;16 (23).

Breast cancer
Takeda A, Jones J, Loveman E, Tan SC, Clegg AJ. The clinical and cost effectiveness of gemcitabine for metastatic breast cancer: a systematic review and economic evaluation. Health Technology Assessment 2007;11(19).

Picot J, Copley V, Colquitt JL, Kalita N, Hartwell D, Bryant J. The INTRABEAM® Photon Radiotherapy System for the adjuvant treatment of early breast cancer: a systematic review and economic evaluation. Health Technology Assessment 2015; 19(69).

Liver cancer
Loveman E, Jones J, Clegg A, Picot J, Colquitt J, Mendes D, et al. The clinical effectiveness and cost effectiveness of ablative therapies in the management of liver metastases: systematic review and economic modelling study. Health Technology Assessment 2014;18(7).

Lung cancer

Pink J, Loveman E, Taggat F et al. Ceritinib for previously treated anaplastic lymphoma kinase positive non-small-cell lung cancer. A Single Technology Appraisal. 2016

Loveman E, Cummins E, Connock M et al. Ramucirumab for previously treated locally advanced or metastatic non-small-cell lung cancer. A Single Technology Appraisal. 2016

Pickett K, Rose M, Colquitt J et al. Necitumumab for untreated advanced or metastatic squamous non-small-cell lung cancer. A Single Technology Appraisal. 2016

Hartwell D, Jones J, Loveman E, Harris P, Clegg A, and Bird A. Topotecan for relapsed small cell lung cancer: a systematic review and economic evaluation. Cancer Treatment Reviews 2011;37:242-249.

Loveman E, Jones J, Hartwell D, Bird A, Harris P, Welch K et al. The clinical and cost effectiveness of topotecan for small cell lung cancer: a systematic review and economic evaluation. Health Technology Assessment 2010;4(19)

Back to main publications page

  • Scoping
  • Protocol
  • Literature searching
  • Eligibility screening
  • Data extraction and critical appraisal
  • Data synthesis
  • Conclusions and recommendations